The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
28-Mar-22
Pending
~$1.4 billion
Target:
Theramex
Acquiror:
Carlyle and PAI Partners
Advising Carlyle, the leading private equity investor, on the acquisition of Theramex, a Women’s health-focused specialty pharmaceutical company . The acquisition was jointly executed with PAI Partners
28-Mar-22
Pending
$105 million
Target:
Acacia Pharma Group plc
Acquiror:
Eagle Pharmaceuticals, Inc.
Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise
18-Mar-22
Pending
~$190 million
Target:
Veritiv Canada
Acquiror:
Imperial Dade
Advising Veritiv Corporation, a leading North American distributor of packaging, facility solutions, print and publishing products and services, on the sale of Veritiv Canada, Inc. to Imperial Dade, a portfolio company of Bain Capital
22-Feb-22
Pending
~$8.6 billion
Target:
TEGNA, Inc.
Acquiror:
Standard General
Advising TEGNA, a leading broadcasting and digital marketing services company, on its sale to Standard General, a hedge fund
16-Feb-22
Undisclosed
Target:
Liontown Resources
Acquiror:
Offtake Agreement with Tesla
Advised Liontown Resources, an ASX-listed lithium company focused on the development of the world class Kathleen Valley Lithium Project, on a lithium spodumene concentrate offtake agreement with Tesla, a major electric vehicle manufacturer
02-Feb-22
Pending
$247 million
Target:
Telxius Telecom
Acquiror:
Consortium of Telefónica and Pontegadea
Advising KKR, on the disposal of its 40% stake in Telxius Telecom, a global telecommunications infrastructure company, to a consortium formed by Telefónica and Pontegadea
01-Feb-22
Undisclosed
Target:
Alteon Health
Acquiror:
U.S. Acute Care Solutions
Advised Alteon Health, a portfolio company of New Mountain Capital and national physician-led provider of emergency medicine, hospitalist medicine and post-acute care services, on its sale to U.S. Acute Care Solutions
28-Jan-22
Undisclosed
Target:
Akorn Pharmaceuticals Portfolio of Branded Ophthalmic Products
Acquiror:
Laboratoires Théa SAS
Advised Akorn Pharmaceuticals, a specialty pharmaceuticals manufacturer and marketer, on the divestiture of its portfolio of branded ophthalmic products to Laboratoires Théa SAS
20-Jan-22
Pending
Undisclosed
Target:
GrowFlow Corp.
Acquiror:
Dama Financial
Advising Dama Financial, the nation’s largest provider of access to banking and payment solutions for the cannabis industry, on its acquisition of GrowFlow Corp, a leading business management and compliance software platform for cannabis retailers, cultivators, processors, and distributors
18-Jan-22
Undisclosed
Target:
Electra.aero, Inc
Acquiror:
Lockheed Martin Ventures
Advised Electra.aero, a pioneering developer of hybrid-electric ultra-short takeoff and landing (eSTOL) aircraft, on an investment from Lockheed Martin Ventures, to develop a technology demonstrator and accelerate Electra’s path towards certification and entry into commercial service
18-Jan-22
$321 million
Target:
Fusion Connect, Inc.
Acquiror:
N/A
Advised Fusion Connect, Inc., a leading service provider of cloud communications and secure network solutions with a focus on serving mid-market and enterprise businesses on its comprehensive balance sheet recapitalization
12-Jan-22
Undisclosed
Target:
Liontown Resources
Acquiror:
Offtake Agreement with LG Energy Solutions
Advised Liontown Resources, an ASX-listed lithium company focused on the development of the world class Kathleen Valley Lithium Project, on a lithium spodumene concentrate offtake agreement with LG Energy Solutions, a major South Korean-based EV battery supplier for leading global automakers
05-Jan-22
Pending
Undisclosed
Target:
Emitel S.A.
Acquiror:
Cordiant Digital Infrastructure Limited
Advised Cordiant Digital Infrastructure Limited, a UK-listed Investment Trust, on the acquisition of Emitel S.A., a Polish telecom tower infrastructure business
31-Dec-21
Pending
Undisclosed
Target:
Portfolio of Over 700 MWp of Solar PV Development Assets
Acquiror:
BayWa r.e.
Quercus, a specialist investor in renewable energy, has agreed to sell a portfolio of over 700 MWp of solar PV development assets in Spain to BayWa r.e., an entity jointly owned by BayWa AG and Energy Infrastructure Partners
30-Dec-21
$100 million
Target:
Photonics Division of Intevac
Acquiror:
EOTech LLC
Advised Intevac, a leading developer of thin-film processing systems for the electronics market and high-sensitivity digital sensors for the defense industry, on the sale of its Photonics division to EOTech, a manufacturer of holographic sighting systems and accessories for military and commercial customers
23-Dec-21
Undisclosed
Target:
Syrah Resources
Acquiror:
Offtake Agreement with Tesla, Inc
Advised Syrah Resources, an ASX-listed industrial minerals and technology company, on a natural graphite active anode material offtake agreement with Tesla, the world’s largest EV manufacturer
21-Dec-21
Pending
Undisclosed
Target:
Jaybro
Acquiror:
Quadrant Private Equity
Advising CPE Capital on the sale of Jaybro, the leading distributor of supplies to infrastructure workers across Australia and New Zealand, to Quadrant Private Equity
17-Dec-21
N.A.
Target:
MRO Holdings, Inc. (Panama)
Acquiror:
N.A.
Advised MRO Holdings, a leading airframe maintenance, repair and overhaul (“MRO”) services provider in the Americas, on its term loan financing
16-Dec-21
$1.3 billion
Target:
Kaman Distribution Group
Acquiror:
Genuine Parts Company
Advised Genuine Parts Company, a leading distributor of automotive replacement and industrial parts , on the acquisition of Kaman Distribution Group, a leading North American distributor of industrial parts
15-Dec-21
$125 million
Target:
Helloworld Travel Limited’s Corporate and Entertainment Travel Business in Australia and New Zealand
Acquiror:
Corporate Travel Management
Adviser to CTM, a leading ASX-listed corporate travel management company, on the A$175m acquisition of Helloworld’s corporate and entertainment travel business, and associated A$100m equity raising
08-Dec-21
$240 million
Target:
Alert 360
Acquiror:
My Alarm Center
Advising My Alarm Center, a nationwide provider of security and smart home monitoring services, on the acquisition of Alert 360, a leading competitor in the alarm monitoring industry
08-Dec-21
Pending
Undisclosed
Target:
Pet Circle
Acquiror:
Various global growth investors, including TDM Growth Partners, Prysm Capital, AirTree Ventures and Baillie Gifford
Advising Pet Circle, Australia’s leading online specialty pet company, on its unicorn Series C funding round, which included a A$125m primary capital raise
07-Dec-21
Pending
Undisclosed
Target:
Interamericana Trading Corporation and Simpson Motors
Acquiror:
Inchcape plc
Advising Inchcape plc, the leading independent global automotive distributor, on the acquisition of Interamericana Trading Corporation (“ITC”), a leading independent automotive distributor in the Caribbean region, and Simpson Motors, the leading automotive retailer in Barbados, from the Simpson Group
07-Dec-21
$153 million
Target:
Japan Medical Dynamic Marketing
Acquiror:
Mitsui Chemicals
Advising Mitsui Chemicals, one of the largest Japanese chemical companies, on the acquisition of a 30% stake in Japan Medical Dynamic Marketing, a leading orthopedic medical device manufacturer in Japan, held by NGK SPARK PLUG
01-Dec-21
$353 million
Target:
Liontown Resources
Acquiror:
N/A
Advised Liontown Resources, an ASX-listed lithium company focused on the development of the world class Kathleen Valley Lithium Project, on its A$490m equity raising, comprised of a fully underwritten placement of A$450m and a non-underwritten share purchase plan of A$40m